Founded in 2014 by Dr. Christopher Otiko, ViaDerma Inc. (VDRM) is a publicly traded pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas.
ViaDerma’s lead product Vitastem utilizes an innovative transdermal delivery method to apply any active ingredient to a topical drug. This unique dual carrier transdermal technology can be applied into products within the medical and cosmetics markets. Vitastem is one of the best and most powerful topical antibiotics in the world.
With over 10 years of rigorous clinical testing, multiple patents, and more – ViaDerma has produced the most advanced transdermal delivery system that treats numerous infectious diseases far better and faster than any products currently on the market.